Raymond James Financial Inc.
Managing director, co-head of health care investment banking
New Company Website
Managing director, head of west coast biotechnology investment banking
Raymond James has hired experienced finance professional Andrew Gitkin as managing director and co-head of the firm’s Health Care Investment Banking practice. Along with Managing Director Riley Sweat, Gitkin will co-lead the firm’s health care investment banking efforts. Specifically, he will focus on the life sciences and biotechnology sector – an area in which he is deeply experienced and has served for the last 15 years of his career. He will be based in Los Angeles in the investment banking division’s newly established office.
“Andrew is a highly regarded professional with an exceptional understanding of the biotech, life sciences and health care space,” said Jim Bunn, president of Raymond James Global Equities and Investment Banking group. “He’s built an exceptional reputation in the sector and is adept at delivering results to clients, so we are thrilled to welcome him to our team and lead our efforts in this area.”
Gitkin joins Raymond James from Piper Jaffray where he led the West Coast biotech investment banking practice. Prior to Piper Jaffray, Gitkin was an investment banker with Moelis & Company. Earlier in his career, Gitkin was a health care portfolio manager at both Tavistock Life Sciences and Saddle Point Asset Management and worked in health care equity research at Salomon Smith Barney and Paine Webber/UBS and was awarded rankings by both Institutional Investor and Greenwich Associates, as well as winning recognition in Crain’s Business “40 under 40.
Gitkin earned a bachelor’s degree in business administration from Emory University’s Goizueta Business School in Atlanta, Georgia.
“I am very excited to join my co-head Riley Sweat and the highly successful Raymond James Health Care Investment Banking team,” said Gitkin. “Over the last few years both the bankers and the equity research analysts have established a strong reputation in the life sciences area; and Raymond James, overall, has built a powerful global banking platform that I am looking forward to leveraging on behalf of my clients and helping to grow, particularly in the important West Coast market.”
Raymond James will be hosting its inaugural Life Sciences and MedTech Conference in New York, June 18-19, 2019. Sweat and Gitkin along with the Raymond James health care/biotech equity research analysts’ team will welcome key executives from top companies in the biotechnology, pharmaceutical and medical technology sectors.